News

SmartCella granted new European patent for the Extroducer delivery platform

November 12, 2024 08:45 CET

XyloCor Therapeutics and SmartCella Enter into License Agreement for Use of the Extroducer Infusion Catheter System to Administer Novel Gene Therapy XC001 to the Heart

July 10, 2024 14:08 CEST

SmartCella raises EUR 50 million to accelerate growth and commercialization

July 8, 2024 08:00 CEST

Senior life science and medical specialists join SmartCella’s Board of Directors

June 12, 2024 09:00 CEST

SmartCella strengthens team with Dr Ricardo Baptista as CTO

April 19, 2024 11:02 CEST

CEO comments on the full year of 2023

April 11, 2024 10:05 CEST

SmartCella AB appoints Oskar Steneryd as new CFO

March 19, 2024 09:00 CET

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

February 7, 2024 09:00 CET

SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer

January 3, 2024 11:33 CET

Q2 update on the SmartCella family

September 9, 2023 11:56 CEST

Niklas Prager appointed new CEO of SmartCella

May 11, 2023 09:00 CEST

FDA approval for Smartwise Extroducer

June 13, 2022 09:00 CEST

Procella published in Nature Cell Biology

May 12, 2022 08:00 CEST

SmartCella Holding AB raises SEK 328 million to advance and accelerate development of the company’s technologies

September 27, 2021 13:23 CEST

Procella Therapeutics and Smartwise enter collaboration with AstraZeneca to develop novel cardiovascular and catheter-based therapies

May 7, 2018 16:03 CEST